Skip to main content

This job has expired

You will need to login before you can apply for a job.

Early Assets and Hematology Team Intern

Employer
Daiichi Sankyo
Location
Basking Ridge, NJ
Start date
Nov 1, 2024
View more categoriesView less categories

Job Details

Join a Legacy of Innovation 125 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

We are currently seeking a Global Regulatory Affairs Intern for summer 2025. This full time position works for approximately 37.5 hours per week.

Responsibilities: 

  • The selected interns will work with assigned mentors on projects to help improve leadership, problem solving, and critical thinking skills
  • Experience different disease-therapeutic areas, and associated regulatory areas including Product Labeling, Chemistry, Manufacturing and Controls, Policy and Intelligence
  • Work with knowledgeable mentors and develop skills to build a strong career foundation!
  • Work on programs and strategies for compounds in development and/or marketed products
  • Use creative problem-solving skillsets, to develop new ideas and insights, including takeaways about yourself as a leader
  • Interns will be assigned to projects to help and support the regulatory leads and will be required to manage their time appropriately without major supervision.
  • The interns will be required to make a final presentation in terms of their learnings from the program and may be asked to provide recommendation about the improvement needed for the future interns.
  • The intern will be provided a topic that is related to global regulatory issues/challenges with the help of their individual mentors.
  • The intern will participate in certain department activities and initiatives related to the project.

Education/Experience:

  • Currently enrolled full-time and have completed at least 3 years in an undergraduate program, or enrolled full-time in a graduate program, pursuing a degree majoring in a scientific, technology, pharmacy or engineering related field
  • Examples include, pharmacy, biomedical engineering and other biological other healthcare science
  • Pharm D Students that are currently enrolled in P2 and P3 along with those that are enrolled in master’s degree from an accredited DRA Program are also encouraged to apply.
  • Possess a can-do approach, and courage to speak your voice and suggest innovative ideas
  • Detail-oriented, highly motivated, able to manage multiple tasks and to work independently and as a team member.
  • Students with demonstrated leadership skills in projects at home and abroad will be preferred.
  • Good communication skills are a must.

Prior experience in a corporate business environment is preferred; experience in the pharmaceutical industry is a plus.

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer.  All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Company

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.

With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

For more information, please visit: www.daiichisankyo.com.

Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit www.dsi.com.

STOCK EXCHANGE: Tokyo Stock Exchange

STOCK SYMBOL: 4568

Twitter

Company info
Website
Phone
(908) 992-6400
Location
211 Mt. Airy Road
Basking Ridge
New Jersey
07920
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert